Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis

The Prostate
Tracy DanielsCarlos A Casiano

Abstract

Cancer patients produce autoantibodies to self-proteins called tumor-associated antigens (TAA). These autoantibodies represent potentially valuable tools for identifying novel biomarkers and therapeutic targets. This study was designed to identify TAA in prostate cancer (PCa). Serum autoantibodies to the survival protein lens epithelium-derived growth factor p75 (LEDGF/p75) were detected by immunofluorescence microscopy, ELISA, and immunoblotting. Expression of LEDGF/p75 in prostate cells and tumors was evaluated by immunoblotting or immunohistochemistry. Apoptotic cleavage of LEDGF/p75 was detected by immunoblotting. Anti-LEDGF/p75 autoantibodies were detected by ELISA in 18.4% of PCa patients and 5.5% of matched controls (P < 0.001) but not in patients with benign prostatic hyperplasia (BPH). LEDGF/p75 expression was detected in 93% of prostate tumors but not in normal prostate. Strong expression of the protein was observed in 61% of prostate tumors. Moderate to high expression was also detected in BPH tissue. Cleavage of LEDGF/p75 was detected in apoptotic prostate cells. The high expression of LEDGF/p75 in prostate tumors and BPH could be induced by inflammation and oxidative stress. LEDGF/p75 cleavage fragments generated d...Continue Reading

References

Oct 1, 1976·British Journal of Urology·R J Ablin
Dec 1, 1990·The Journal of Clinical Endocrinology and Metabolism·T LiangS Liao
Jan 1, 1997·Journal of the National Cancer Institute·M O RippleG Wilding
May 23, 1998·The Journal of Experimental Medicine·E StockertL J Old
Dec 5, 1998·British Journal of Urology·C LangT Zwergel
Dec 14, 1999·The American Journal of Pathology·A M De MarzoW G Nelson
Jan 7, 2000·Biochemical and Biophysical Research Communications·D P SinghT Shinohara
Feb 5, 2000·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·S OttonelloG Maraini
May 10, 2000·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·T ShinoharaL T Chylack
Jun 16, 2000·The Journal of Allergy and Clinical Immunology·R L OchsE M Tan
Aug 29, 2000·The Prostate·N B GibbonsJ M Fitzpatrick
Sep 12, 2000·Nature Cell Biology·J M BrueyC Garrido
Oct 26, 2000·Nature·J Savill, V Fadok
Nov 30, 2000·Arthritis Research·P J UtzP Anderson
Feb 22, 2001·Free Radical Biology & Medicine·J FuchsM Podda
Apr 18, 2001·International Archives of Allergy and Immunology·A TrautmannC A Akdis
Jul 24, 2001·Clinical Immunology : the Official Journal of the Clinical Immunology Society·J Y ZhangE M Tan
Nov 21, 2001·The Journal of Clinical Investigation·E M Tan
Jan 12, 2002·Biochemical and Biophysical Research Communications·Yaling ZhouMichael L Salgaller
Jan 31, 2002·Upsala Journal of Medical Sciences·B O NilssonG Ronquist
Feb 14, 2002·The Journal of Allergy and Clinical Immunology·Axel TrautmannCezmi A Akdis
Jun 8, 2002·Progress in Retinal and Eye Research·Toshimichi ShinoharaNigar Fatma
Sep 5, 2002·The Journal of Allergy and Clinical Immunology·Russell P Bowler, James D Crapo
Dec 24, 2002·Nature Biotechnology·Paul J MintzWadih Arap
May 6, 2003·Biochemical and Biophysical Research Communications·Arnaud ParcellierCarmen Garrido
Jun 11, 2003·The Journal of Biological Chemistry·Goedele MaertensYves Engelborghs
Jul 25, 2003·The New England Journal of Medicine·William G NelsonWilliam B Isaacs
Sep 11, 2003·Autoimmunity Reviews·Vidya GanapathyCarlos A Casiano
Nov 18, 2003·Clinical and Experimental Immunology·E M Tan, F-D Shi
Jan 10, 2004·The Journal of Urology·M Scott Lucia, Kathleen C Torkko
Jan 30, 2004·Cancer Immunology, Immunotherapy : CII·Alexander FossåErlend B Smeland

❮ Previous
Next ❯

Citations

Jul 10, 2012·Nature Structural & Molecular Biology·Mads DaugaardMarja Jäättelä
Feb 27, 2009·The Journal of Biological Chemistry·Koen BartholomeeusenJan De Rijck
May 31, 2006·Molecular & Cellular Proteomics : MCP·Carlos A CasianoEng M Tan
Feb 12, 2013·Nucleic Acids Research·Jocelyn O EidahlMamuka Kvaratskhelia
Aug 19, 2008·Molecular Cancer Research : MCR·Terry A Brown-BryanCarlos A Casiano
Oct 1, 2009·Future Medicinal Chemistry·Arnout Rd VoetFrauke Christ
May 27, 2014·Journal of Immunology Research·Liping DaiJian-Ying Zhang
Feb 12, 2008·Cellular and Molecular Life Sciences : CMLS·E M Poeschla
Oct 17, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Nicola BizzaroDanilo Villalta
Dec 8, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dennis J O'RourkeBrian C-S Liu
Dec 21, 2010·Autoimmunity Reviews·Weihong LiuJian-Ying Zhang
Aug 4, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Anamika BasuCarlos A Casiano
Jul 22, 2006·The Journal of Investigative Dermatology·Kazumitsu SugiuraJiro Usukura
Aug 3, 2007·Journal of Molecular Biology·Koen BartholomeeusenFrauke Christ
Dec 2, 2006·Journal of Molecular Biology·Katrien BusschotsFrauke Christ
Sep 7, 2007·Annals of the New York Academy of Sciences·Nicola BizzaroEnrico Vigevani
Sep 10, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Claudia CavalluzzoErik Van der Eycken
Oct 29, 2009·The FEBS Journal·Hwee Tong TanMaxey C M Chung
Jan 13, 2006·Trends in Biochemical Sciences·Bénédicte Van MaeleZeger Debyser
Mar 12, 2013·Clinical & Developmental Immunology·Makoto MiyaraMichael Mahler
Jun 29, 2016·Clinical Reviews in Allergy & Immunology·Karsten ConradMichael Mahler
Jul 30, 2016·Scientific Reports·Yuan ChenZheming Yuan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis